Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
Kelsen, Judith R; Dawany, Noor; Conrad, Maire; Devoto, Marcella.
Inflamm Bowel Dis
; 23(4): 591-592, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28267048
Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations.
Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report.
IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms.
Influence of Toll-like receptor 2 and interleukin 10 on the intestinal epithelial barrier and their roles in inflammatory bowel disease
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease.
Inflamed gut mucosa: downstream of interleukin-10.
Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.